News
FDA Commissioner Marty Makary has revealed a new priority review voucher programme for new medicines deemed to be of national ...
The Commissioner's National Priority Voucher (CNPV) programme will be available to companies aligned with pressing matters ...
59m
LUND, Sweden, June 18, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced topline results from the 12-month, randomized, double-blind, placebo-controlled POSITANO Phase 2b study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback